Regulatory Approval - Europe's drug regulator backed GSK's drug [1] - This is the first such recommendation globally for this medicine [1] Pharmaceutical Industry Impact - The drug is pegged to become a blockbuster [1] - The drug is for treating severe asthma or a common nasal condition [1]